Inventor
PAONI NICHOLAS F
US35 patents
Patents
35 patentsUS6635468B2Oct 21, 2003
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC92 citations99
US7026448B2Apr 11, 2006
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC35 citations96
US5262170ANov 16, 1993
Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
GENENTECH INC22 citations96
US7390879B2Jun 24, 2008
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC36 citations92
US6974689B1Dec 13, 2005
Nucleic acid encoding PRO211 polypeptides
GENENTECH INC27 citations92
US6723535B2Apr 20, 2004
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC14 citations92
US5837241ANov 17, 1998
Method of treating heart failure using leukemia inhibitory factor antagonists optionally with endothelin antagonists
GENENTECH INC22 citations92
US5661122AAug 26, 1997
Treatment of congestive heart failure
GENENTECH INC45 citations92
US5612029AMar 18, 1997
Tissue plasminogen activator glycosylation variants with improved therapeutic properties
GENENTECH INC49 citations92
US5610134AMar 11, 1997
Treatment of congestive heart failure
GENENTECH INC23 citations92
US5573762ANov 12, 1996
Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
GENENTECH INC20 citations92
US5108901AApr 28, 1992
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC38 citations92
US6187304B1Feb 13, 2001
Effects of IFN-γ on cardiac hypertrophy
GENENTECH INC15 citations90
US7056736B2Jun 6, 2006
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC9 citations82
US6664376B2Dec 16, 2003
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC9 citations82
US5770426AJun 23, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC7 citations82
US5616486AApr 1, 1997
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC13 citations82
US5520913AMay 28, 1996
Tissue plasminogen activator having zymogenic properties
GENENTECH INC13 citations82
US5411871AMay 2, 1995
Method for identifying tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC10 citations82
US5405771AApr 11, 1995
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC12 citations82
US7196165B2Mar 27, 2007
PRO363 polypeptides
GENENTECH INC6 citations74
US7026449B2Apr 11, 2006
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC10 citations74
US5840564ANov 24, 1998
Tussue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC4 citations74
US5714145AFeb 3, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC12 citations74
US6156733ADec 5, 2000
Use of leukemia inhibitory factor and endothelin antagonists
GENENTECH INC10 citations73
US7034123B2Apr 25, 2006
Anti-PRO1347 antibodies
GENENTECH INC0 citations63
US5736134AApr 7, 1998
Tissue plasminogen activator variants
GENENTECH INC3 citations63
US5728567AMar 17, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC1 citations63
US5614190AMar 25, 1997
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC1 citations63
US7208308B2Apr 24, 2007
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC0 citations62
US6989364B1Jan 24, 2006
Methods for treating cardiac hypertrophy by administering IFN-γ
GENENTECH INC2 citations60
US7317092B2Jan 8, 2008
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC1 citations52
US5821105AOct 13, 1998
Tissue plasminogen activator having zymognic or fibrin specific properties
GENENTECH INC0 citations52
US5756093AMay 26, 1998
Tissue plasminogen activator variants
GENENTECH INC0 citations52
US6653287B1Nov 25, 2003
Use of leukemia inhibitory factor and endothelin antagonists
GENENTECH INC0 citations51